A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

NCT06016842 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Biliary Cholangitis (PBC)

Interventions

DRUG: Elafibranor
OTHER: Matched 80 mg placebo

Sponsor

Ipsen